Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,364

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Cooperation of Toll-like receptor signals in innate immune defence

Trinchieri, Giorgio, Sher, Alan·2007·Nature Reviews Immunology
DOI 10.1038/nri2038
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nri2038

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 90

  1. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006). A comprehensive review of TLR biology. · DOI · Paper page
  2. Lemaitre, B. The road to Toll. Nature Rev. Immunol. 4, 521–527 (2004). · DOI · Paper page
  3. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997). A pioneering report describing Toll-like signalling molecules in a higher vertebrate. · DOI · Paper page
  4. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M. & Hoffmann, J. A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973–983 (1996). Characterization of the role of Toll in resistance to pathogens of D. melanogaster. · DOI · Paper page
  5. Fritz, J. H. & Girardin, S. E. How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J. Endotoxin Res. 11, 390–394 (2005). · DOI
  6. Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G. & Marshak-Rothstein, A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204, 27–42 (2005). · DOI · Paper page
  7. Iwasaki, A. & Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nature Immunol. 5, 987–995 (2004). This paper describes the differential expresssion of TLRs by different antigen-presenting cells. · DOI · Paper page
  8. Uematsu, S. et al. Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nature Immunol. 7, 868–874 (2006). · DOI · Paper page
  9. Beutler, E., Gelbart, T. & West, C. Synergy between TLR2 and TLR4: a safety mechanism. Blood Cells Mol. Dis. 27, 728–730 (2001). · DOI
  10. Sato, S. et al. Synergy and cross-tolerance between toll-like receptor (TLR)2- and TLR4-mediated signaling pathways. J. Immunol. 165, 7096–7101 (2000). References 13 and 14 are early reports of cooperation between TLRs. · DOI · Paper page
  11. Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869–8872 (2003). · DOI · Paper page
  12. Whitmore, M. M. et al. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res. 64, 5850–5860 (2004). The first study to describe the use of multiple TLR ligands to increase host resistance. · DOI
  13. Gautier, G. et al. A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12 p70 secretion by dendritic cells. J. Exp. Med. 201, 1435–1446 (2005). · DOI · Paper page
  14. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F. & Lanzavecchia, A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nature Immunol. 6, 769–776 (2005). References 17 and 18 are the first reports to describe the strong synergistic effects of TLR ligands on IL-12 p70 production by DCs. · DOI · Paper page
  15. Re, F. & Strominger, J. L. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of TH1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J. Immunol. 173, 7548–7555 (2004). One of the early studies showing differential and antagonistic functional consequences of the activation of different TLRs. · DOI
  16. Roelofs, M. F. et al. The expression of Toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of Toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 52, 2313–2322 (2005). · DOI · Paper page
  17. Ma, X. et al. The interleukin 12 p40 gene promoter is primed by interferon-γ in monocytic cells. J. Exp. Med. 183, 147–157 (1996). · DOI · Paper page
  18. Edwards, A. D. et al. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169, 3652–3660 (2002). · DOI
  19. Abdi, K., Singh, N. & Matzinger, P. T-cell control of IL-12p75 production. Scand. J. Immunol. 64, 83–92 (2006). · DOI
  20. Bekeredjian-Ding, I. et al. T cell-independent, TLR-induced IL-12p70 production in primary human monocytes. J. Immunol. 176, 7438–7446 (2006). · DOI
  21. Liu, J., Guan, X., Tamura, T., Ozato, K. & Ma, X. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J. Biol. Chem. 279, 55609–55617 (2004). · DOI
  22. Hasan, U. A., Trinchieri, G. & Vlach, J. Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts. J. Biol. Chem. 280, 20620–20627 (2005). · DOI
  23. Schulz, O. et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13, 453–462 (2000). · DOI · Paper page
  24. Bagchi, A. et al. MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J. Immunol. 178, 1164–1171 (2007). A recent report documenting synergy between MyD88- and TRIF-dependent signalling by TLR agonists. · DOI · Paper page
  25. Bafica, A. et al. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177, 3515–3519 (2006). The first description of TLR cooperation in host defence against a protozoan pathogen. · DOI · Paper page
  26. Kagan, J. C. & Medzhitov, R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943–955 (2006). · DOI · Paper page
  27. Rhee, S. H., Jones, B. W., Toshchakov, V., Vogel, S. N. & Fenton, M. J. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J. Biol. Chem. 278, 22506–22512 (2003). · DOI
  28. Dahlberg, A., Auble, M. R. & Petro, T. M. Reduced expression of IL-12 p35 by SJL/J macrophages responding to Theiler's virus infection is associated with constitutive activation of IRF-3. Virology 353, 422–432 (2006). · DOI
  29. Honda, K. et al. Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035–1040 (2005). · DOI · Paper page
  30. van Heel, D. A. et al. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur. J. Immunol. 35, 2471–2476 (2005). · DOI
  31. Fritz, J. H. et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 35, 2459–2470 (2005). · DOI · Paper page
  32. Uehara, A. et al. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7, 53–61 (2005). · DOI
  33. Tada, H., Aiba, S., Shibata, K., Ohteki, T. & Takada, H. Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73, 7967–7976 (2005). · DOI · Paper page
  34. Watanabe, T., Kitani, A., Murray, P. J. & Strober, W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunol. 5, 800–808 (2004). · DOI · Paper page
  35. Kobayashi, K. S. et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731–734 (2005). · DOI · Paper page
  36. Watanabe, T., Kitani, A. & Strober, W. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease. Gut 54, 1515–1518 (2005). · DOI
  37. van Heel, D. A. et al. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 54, 1553–1557 (2005). · DOI
  38. Strober, W., Murray, P. J., Kitani, A. & Watanabe, T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Rev. Immunol. 6, 9–20 (2006). · DOI · Paper page
  39. Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213–218 (2004). · DOI · Paper page
  40. Dinarello, C. A. Unraveling the NALP-3/IL-1β inflammasome: a big lesson from a small mutation. Immunity 20, 243–244 (2004). · DOI
  41. Kanneganti, T. D. et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281, 36560–36568 (2006). · DOI · Paper page
  42. Ogura, Y., Sutterwala, F. S. & Flavell, R. A. The inflammasome: first line of the immune response to cell stress. Cell 126, 659–662 (2006). · DOI · Paper page
  43. Gitlin, L. et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl Acad. Sci. USA 103, 8459–8464 (2006). · DOI · Paper page
  44. Underhill, D. M. & Ozinsky, A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20, 825–852 (2002). · DOI · Paper page
  45. Pathak, S. K. et al. Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. J. Biol. Chem. 280, 42794–42800 (2005). · DOI
  46. Yadav, M. & Schorey, J. S. The β-glucan receptor Dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108, 3168–3175 (2006). · DOI · Paper page
  47. Rogers, N. C. et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C-type lectins. Immunity 22, 507–517 (2005). · DOI · Paper page
  48. Netea, M. G. et al. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J. Leukocyte Biol. 80, 1454–1461 (2006). · DOI
  49. Radsak, M. P., Salih, H. R., Rammensee, H. G. & Schild, H. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J. Immunol. 172, 4956–4963 (2004). · DOI
  50. Turnbull, I. R. et al. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520–3524 (2006). · DOI · Paper page
  51. Cappiello, M. G., Sutterwala, F. S., Trinchieri, G., Mosser, D. M. & Ma, X. Suppression of IL-12 transcription in macrophages following Fcγ receptor ligation. J. Immunol. 166, 4498–4506 (2001). · DOI
  52. Merck, E. et al. Ligation of the FcRγ chain-associated human osteoclast-associated receptor enhances the proinflammatory responses of human monocytes and neutrophils. J. Immunol. 176, 3149–3156 (2006). · DOI
  53. Palliser, D., Ploegh, H. & Boes, M. Myeloid differentiation factor 88 is required for cross-priming in vivo. J. Immunol. 172, 3415–3421 (2004). · DOI
  54. Sun, D. & Ding, A. MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA. Nature Immunol. 7, 375–381 (2006). · DOI
  55. Reiling, N. et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169, 3480–3484 (2002). · DOI · Paper page
  56. Wang, T. et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature Med. 10, 1366–1373 (2004). · DOI · Paper page
  57. Kurt-Jones, E. A. et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl Acad. Sci. USA 101, 1315–1320 (2004). References 70 and 71 describe the detrimental effects of specific TLR signals in viral infection. · DOI · Paper page
  58. Sutmuller, R. P. et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116, 485–494 (2006). This study describes how TLR signalling can negatively regulate immune responses through the induction of regulatory T cells. · DOI · Paper page
  59. Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl Acad. Sci. USA 101, 3516–3521 (2004). · DOI · Paper page
  60. Szomolanyi-Tsuda, E., Liang, X., Welsh, R. M., Kurt-Jones, E. A. & Finberg, R. W. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J. Virol. 80, 4286–4291 (2006). · DOI
  61. Delale, T. et al. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-α release and initiation of immune responses in vivo. J. Immunol. 175, 6723–6732 (2005). · DOI
  62. O'Brien, A. D. et al. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J. Immunol. 124, 20–24 (1980). · DOI · Paper page
  63. Beutler, B. TLR4 as the mammalian endotoxin sensor. Curr. Top. Microbiol. Immunol. 270, 109–120 (2002).
  64. Weiss, D. S., Raupach, B., Takeda, K., Akira, S. & Zychlinsky, A. Toll-like receptors are temporally involved in host defense. J. Immunol. 172, 4463–4469 (2004). An early paper describing TLR cooperation in the control of bacterial infection. · DOI
  65. Koga, R. et al. TLR-dependent induction of IFN-β mediates host defense against Trypanosoma cruzi. J. Immunol. 177, 7059–7066 (2006). The first report of cooperation of TRIF- and MyD88-dependent signalling pathways in host defence in vivo. · DOI
  66. Taylor, G. A., Feng, C. G. & Sher, A. p47 GTPases: regulators of immunity to intracellular pathogens. Nature Rev. Immunol. 4, 100–109 (2004). · DOI · Paper page
  67. Oliveira, A. C. et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 173, 5688–5696 (2004). · DOI
  68. Turvey, S. E. & Hawn, T. R. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin. Immunol. 120, 1–9 (2006). A recent review of the effect of human TLR polymorphisms on host resistance to infectious diseases. · DOI
  69. Ku, C. L. et al. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev. 203, 10–20 (2005). · DOI
  70. Krieg, A. M. Therapeutic potential of Toll-like receptor 9 activation. Nature Rev. Drug Discov. 5, 471–484 (2006). · DOI · Paper page
  71. Wille-Reece, U. et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of TH1 and CD8+ T cell responses in nonhuman primates. Proc. Natl Acad. Sci. USA 102, 15190–15194 (2005). This study describes the effects of coupling a TLR ligand to antigen on the immune response induced to a vaccine antigen in a primate model. · DOI · Paper page
  72. Yarovinsky, F., Kanzler, H., Hieny, S., Coffman, R. L. & Sher, A. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response. Immunity 25, 655–664 (2006). · DOI
  73. Warger, T. et al. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 108, 544–550 (2006). · DOI
  74. Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413–424 (2006). · DOI · Paper page
  75. Sato, S. et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171, 4304–4310 (2003). · DOI · Paper page
  76. Levy, D. E., Marie, I., Smith, E. & Prakash, A. Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 22, 87–93 (2002). · DOI
  77. Honda, K. et al. Role of a transductional–transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl Acad. Sci. USA 101, 15416–15421 (2004). · DOI · Paper page
  78. Kawai, T. et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunol. 5, 1061–1068 (2004). · DOI · Paper page
  79. Barnes, B. J., Moore, P. A. & Pitha, P. M. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon-α genes. J. Biol. Chem. 276, 23382–23390 (2001). · DOI · Paper page
  80. Guiducci, C. et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203, 1999–2008 (2006). · DOI · Paper page
  81. Netea, M. G. et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116, 1642–1650 (2006). · DOI · Paper page
  82. Cambi, A., Koopman, M. & Figdor, C. G. How C-type lectins detect pathogens. Cell. Microbiol. 7, 481–488 (2005). · DOI · Paper page
  83. Nimmerjahn, F. & Ravetch, J. V. Fcγ receptors: old friends and new family members. Immunity 24, 19–28 (2006). · DOI · Paper page
  84. Bouchon, A., Facchetti, F., Weigand, M. A. & Colonna, M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410, 1103–1107 (2001). · DOI · Paper page
  85. Wysocka, M. et al. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25, 672–676 (1995). · DOI · Paper page
  86. Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nature Immunol. 2, 1144–1150 (2001). · DOI · Paper page
  87. Byrnes, A. A. et al. Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity. Eur. J. Immunol. 31, 2026–2034 (2001). · doi:10.1002/1521-4141(200107)31:7<2026::aid-immu2026>3.0.co;2-u
  88. Gerosa, F. et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195, 327–333 (2002). · DOI · Paper page
  89. Gerosa, F. et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174, 727–734 (2005). · DOI · Paper page
  90. D'Andrea, A., Ma, X., Aste-Amezaga, M., Paganin, C. & Trinchieri, G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181, 537–546 (1995). · DOI · Paper page

Cited by

Metadata

Authors
Trinchieri, G., & Sher, A.
Venue
Nature Reviews Immunology
Publisher
Springer Science and Business Media LLC
Published
2007-03
Volume
7
Issue
3
Pages
179-190
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
DOI
10.1038/nri2038
OpenAlex
W2036767516
Cited by
1,364
References
15
FWCI
8.70
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.